Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
Titel:
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
Auteur:
Cohen, Jeffrey A Arnold, Douglas L Comi, Giancarlo Bar-Or, Amit Gujrathi, Sheila Hartung, Jeffrey P Cravets, Matt Olson, Allan Frohna, Paul A Selmaj, Krzysztof W